vs
IRONWOOD PHARMACEUTICALS INC（IRWD）与RBB Bancorp（RBB）财务数据对比。点击上方公司名可切换其他公司
IRONWOOD PHARMACEUTICALS INC的季度营收约是RBB Bancorp的1.5倍（$47.7M vs $32.3M），RBB Bancorp净利率更高（31.5% vs -4.8%，领先36.3%），RBB Bancorp同比增速更快（12.6% vs -47.3%），IRONWOOD PHARMACEUTICALS INC自由现金流更多（$74.6M vs $42.6M），过去两年RBB Bancorp的营收复合增速更高（7.0% vs -20.2%）
Ironwood制药公司是一家上市制药企业，其前身为Microbia公司，专注于制药领域相关业务研发与运营，面向市场开发各类创新医药产品，满足未被充分满足的临床医疗需求。
RBB银行控股公司是总部位于美国的金融控股集团，旗下核心主体为皇家商业银行，主要服务亚裔社群、中小微企业、不动产投资者及零售客户，提供商业信贷、储蓄存款、财富管理等多元金融服务，业务覆盖美国沿海核心都会区。
IRWD vs RBB — 直观对比
营收规模更大
IRWD
是对方的1.5倍
$32.3M
营收增速更快
RBB
高出59.9%
-47.3%
净利率更高
RBB
高出36.3%
-4.8%
自由现金流更多
IRWD
多$32.0M
$42.6M
两年增速更快
RBB
近两年复合增速
-20.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $47.7M | $32.3M |
| 净利润 | $-2.3M | $10.2M |
| 毛利率 | — | — |
| 营业利润率 | 14.3% | 39.5% |
| 净利率 | -4.8% | 31.5% |
| 营收同比 | -47.3% | 12.6% |
| 净利润同比 | -200.9% | 132.1% |
| 每股收益（稀释后） | $0.01 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IRWDRBB
| Q4 25 | $47.7M | $32.3M | ||
| Q3 25 | $122.1M | $32.6M | ||
| Q2 25 | $85.2M | $35.8M | ||
| Q1 25 | $41.1M | $28.5M | ||
| Q4 24 | $90.5M | $28.7M | ||
| Q3 24 | $91.6M | $30.3M | ||
| Q2 24 | $94.4M | $27.5M | ||
| Q1 24 | $74.9M | $28.2M |
净利润IRWDRBB
| Q4 25 | $-2.3M | $10.2M | ||
| Q3 25 | $40.1M | $10.1M | ||
| Q2 25 | $23.6M | $9.3M | ||
| Q1 25 | $-37.4M | $2.3M | ||
| Q4 24 | $2.3M | $4.4M | ||
| Q3 24 | $3.6M | $7.0M | ||
| Q2 24 | $-860.0K | $7.2M | ||
| Q1 24 | $-4.2M | $8.0M |
营业利润率IRWDRBB
| Q4 25 | 14.3% | 39.5% | ||
| Q3 25 | 61.8% | 40.7% | ||
| Q2 25 | 53.2% | 36.1% | ||
| Q1 25 | -70.7% | 11.2% | ||
| Q4 24 | 34.8% | 17.6% | ||
| Q3 24 | 28.0% | 31.6% | ||
| Q2 24 | 26.5% | 35.6% | ||
| Q1 24 | 14.7% | 39.9% |
净利率IRWDRBB
| Q4 25 | -4.8% | 31.5% | ||
| Q3 25 | 32.8% | 31.2% | ||
| Q2 25 | 27.7% | 26.1% | ||
| Q1 25 | -90.9% | 8.0% | ||
| Q4 24 | 2.5% | 15.3% | ||
| Q3 24 | 4.0% | 23.1% | ||
| Q2 24 | -0.9% | 26.4% | ||
| Q1 24 | -5.6% | 28.4% |
每股收益（稀释后）IRWDRBB
| Q4 25 | $0.01 | $0.59 | ||
| Q3 25 | $0.23 | $0.59 | ||
| Q2 25 | $0.14 | $0.52 | ||
| Q1 25 | $-0.23 | $0.13 | ||
| Q4 24 | $0.03 | $0.26 | ||
| Q3 24 | $0.02 | $0.39 | ||
| Q2 24 | $-0.01 | $0.39 | ||
| Q1 24 | $-0.03 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $215.5M | $212.3M |
| 总债务越低越好 | — | $119.9M |
| 股东权益账面价值 | $-261.8M | $523.4M |
| 总资产 | $396.9M | $4.2B |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资IRWDRBB
| Q4 25 | $215.5M | $212.3M | ||
| Q3 25 | $140.4M | $234.9M | ||
| Q2 25 | $92.9M | $191.9M | ||
| Q1 25 | $108.5M | $238.8M | ||
| Q4 24 | $88.6M | $257.7M | ||
| Q3 24 | $88.2M | $349.4M | ||
| Q2 24 | $105.5M | $252.8M | ||
| Q1 24 | $121.5M | — |
总债务IRWDRBB
| Q4 25 | — | $119.9M | ||
| Q3 25 | $199.5M | $119.8M | ||
| Q2 25 | $199.3M | $119.7M | ||
| Q1 25 | $199.2M | $119.6M | ||
| Q4 24 | $199.0M | $119.5M | ||
| Q3 24 | $198.8M | $119.4M | ||
| Q2 24 | $198.6M | $119.3M | ||
| Q1 24 | $398.3M | $119.2M |
股东权益IRWDRBB
| Q4 25 | $-261.8M | $523.4M | ||
| Q3 25 | $-264.2M | $514.3M | ||
| Q2 25 | $-308.2M | $517.7M | ||
| Q1 25 | $-334.1M | $510.3M | ||
| Q4 24 | $-301.3M | $507.9M | ||
| Q3 24 | $-311.3M | $509.7M | ||
| Q2 24 | $-321.7M | $511.3M | ||
| Q1 24 | $-330.5M | $514.0M |
总资产IRWDRBB
| Q4 25 | $396.9M | $4.2B | ||
| Q3 25 | $396.1M | $4.2B | ||
| Q2 25 | $342.9M | $4.1B | ||
| Q1 25 | $327.2M | $4.0B | ||
| Q4 24 | $350.9M | $4.0B | ||
| Q3 24 | $389.5M | $4.0B | ||
| Q2 24 | $395.6M | $3.9B | ||
| Q1 24 | $438.8M | $3.9B |
负债/权益比IRWDRBB
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | — | 0.23× | ||
| Q4 24 | — | 0.24× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $74.6M | $43.4M |
| 自由现金流经营现金流 - 资本支出 | $74.6M | $42.6M |
| 自由现金流率自由现金流/营收 | 156.3% | 131.8% |
| 资本支出强度资本支出/营收 | 0.0% | 2.5% |
| 现金转化率经营现金流/净利润 | — | 4.26× |
| 过去12个月自由现金流最近4个季度 | $127.0M | $73.5M |
8季度趋势，按日历期对齐
经营现金流IRWDRBB
| Q4 25 | $74.6M | $43.4M | ||
| Q3 25 | $47.6M | $2.1M | ||
| Q2 25 | $-15.1M | $21.7M | ||
| Q1 25 | $20.0M | $7.8M | ||
| Q4 24 | $15.2M | $58.5M | ||
| Q3 24 | $9.9M | $24.5M | ||
| Q2 24 | $33.5M | $11.7M | ||
| Q1 24 | $45.0M | $4.8M |
自由现金流IRWDRBB
| Q4 25 | $74.6M | $42.6M | ||
| Q3 25 | $47.6M | $1.8M | ||
| Q2 25 | $-15.1M | $21.6M | ||
| Q1 25 | $19.9M | $7.6M | ||
| Q4 24 | — | $57.7M | ||
| Q3 24 | $9.9M | $24.2M | ||
| Q2 24 | $33.4M | $11.5M | ||
| Q1 24 | $44.9M | $4.7M |
自由现金流率IRWDRBB
| Q4 25 | 156.3% | 131.8% | ||
| Q3 25 | 39.0% | 5.4% | ||
| Q2 25 | -17.7% | 60.2% | ||
| Q1 25 | 48.4% | 26.7% | ||
| Q4 24 | — | 201.0% | ||
| Q3 24 | 10.8% | 80.0% | ||
| Q2 24 | 35.4% | 42.0% | ||
| Q1 24 | 60.0% | 16.6% |
资本支出强度IRWDRBB
| Q4 25 | 0.0% | 2.5% | ||
| Q3 25 | 0.0% | 1.1% | ||
| Q2 25 | 0.0% | 0.3% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.0% | 2.7% | ||
| Q3 24 | 0.0% | 0.8% | ||
| Q2 24 | 0.1% | 0.5% | ||
| Q1 24 | 0.1% | 0.5% |
现金转化率IRWDRBB
| Q4 25 | — | 4.26× | ||
| Q3 25 | 1.19× | 0.21× | ||
| Q2 25 | -0.64× | 2.32× | ||
| Q1 25 | — | 3.39× | ||
| Q4 24 | 6.74× | 13.34× | ||
| Q3 24 | 2.71× | 3.50× | ||
| Q2 24 | — | 1.61× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
